| Literature DB >> 33539324 |
Niccolò E Mencacci1,2, Marisa M Brockmann3, Jinye Dai4, Sander Pajusalu5,6,7, Burcu Atasu8,9, Joaquin Campos10, Gabriela Pino10, Paulina Gonzalez-Latapi1, Christopher Patzke4, Michael Schwake1, Arianna Tucci2, Alan Pittman2, Javier Simon-Sanchez8,9, Gemma L Carvill1, Bettina Balint2,11, Sarah Wiethoff2,9,12, Thomas T Warner2,13, Apostolos Papandreou14,15, Audrey Soo14,15, Reet Rein16, Liis Kadastik-Eerme17,18, Sanna Puusepp5,6, Karit Reinson5,6, Tiiu Tomberg19, Hasmet Hanagasi20, Thomas Gasser8,9, Kailash P Bhatia2, Manju A Kurian13,14, Ebba Lohmann8,9, Katrin Õunap5,6, Christian Rosenmund3, Thomas C Südhof4, Nicholas W Wood2, Dimitri Krainc1, Claudio Acuna4,10.
Abstract
Dystonia is a debilitating hyperkinetic movement disorder, which can be transmitted as a monogenic trait. Here, we describe homozygous frameshift, nonsense, and missense variants in TSPOAP1, which encodes the active-zone RIM-binding protein 1 (RIMBP1), as a genetic cause of autosomal recessive dystonia in 7 subjects from 3 unrelated families. Subjects carrying loss-of-function variants presented with juvenile-onset progressive generalized dystonia, associated with intellectual disability and cerebellar atrophy. Conversely, subjects carrying a pathogenic missense variant (p.Gly1808Ser) presented with isolated adult-onset focal dystonia. In mice, complete loss of RIMBP1, known to reduce neurotransmission, led to motor abnormalities reminiscent of dystonia, decreased Purkinje cell dendritic arborization, and reduced numbers of cerebellar synapses. In vitro analysis of the p.Gly1808Ser variant showed larger spike-evoked calcium transients and enhanced neurotransmission, suggesting that RIMBP1-linked dystonia can be caused by either reduced or enhanced rates of spike-evoked release in relevant neural networks. Our findings establish a direct link between dysfunction of the presynaptic active zone and dystonia and highlight the critical role played by well-balanced neurotransmission in motor control and disease pathogenesis.Entities:
Keywords: Genetic diseases; Genetics; Movement disorders; Neuroscience; Synapses
Mesh:
Substances:
Year: 2021 PMID: 33539324 PMCID: PMC8011894 DOI: 10.1172/JCI140625
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808